CAMLINFINE · NSE
Camlin Fine Sciences Limited
₹97.28
-2.36% (-₹2.35)
Prev. close
₹99.63
Volume
13,75,944
Delivery %
59.2%
As of
18 Sept 2026
Price history
No analyst calls on this stock in the last 90 days yet.
Explore by date range →Analyst opinions
Fundamentals
About Camlin Fine Sciences Limited
Camlin Fine Sciences Limited, together with its subsidiaries, research, develops, manufactures, and markets specialty chemicals, ingredients, and additive blend products in India and internationally. The company offers shelf-life solutions, which include basic ingredients, such as tert-butylhydroquinone (TBHQ), Butylated Hydroxyanisole (BHA), Butylated Hydroxytoluene (BHT), and Ascorbyl Palmitate (ASP); aroma ingredients, including vanillin and ethyl vanillin, natural vanillin, and some of its combinations; performance chemicals that include Hydroquinone (HQ), Catechol (CAT), Monomethyl Ether of HQ (MEHQ), tert butylcatechol (TBC), Guaiacol, and Veratrole; and health and wellness products comprising algae based products, such as Omega 3 fatty acids. It sells its products under the Xtendra, Nasure, Ezential, adorr, Vitafor, Dinamic, and Biosus brands. The company's products are used in food and beverage, pet food and rendering, animal nutrition, petrochemical, nutrition and health, biofuel, agrochemical, pharmaceutical, polymers, fragrance and flavor, and dyes and pigments industries. The company was formerly known as Camlin Fine Chemicals Ltd. and changed its name to Camlin Fine Sciences Limited in August 2011. Camlin Fine Sciences Limited was founded in 1931 and is headquartered in Mumbai, India.
Details
Sector
Basic Materials
Industry
Specialty Chemicals
CEO
Mr. Ashish Subhash Dandekar
Headquarters
Mumbai
Employees
674
Website
camlinfs.comExchange
View on NSE ↗Key stats
Market cap
₹1,868.67 Cr
EPS (TTM)
₹-3.08
Beta (1Y · daily vs NIFTY 50)
1.72
Beta (5Y · monthly vs NIFTY 50)
1.95
Shares float
8.88 Cr
EPS · quarter ended Jun 2026
₹-1.65
Financial Performance
01 · Financials
Revenue for Mar 2021–Mar 2022 is as filed with BSE (consolidated), and the first plotted growth figure is computed against Mar 2020 revenue as filed with BSE; the two sources' revenue definitions differ by 0.6% on Mar 2023. FY21 growth needs FY20 filings, which the data source doesn't provide. Net income is omitted from this chart: coverage begins inside the plotted window, and every plotted period must carry a complete point set — the P&L table below has the available figures.
02 · Earnings Per Share (EPS)
04 · Operating Efficiency (Growth Rates)
Balance-sheet-based · pre-FY23 not filed in verifiable form
05 · Capital Structure & Asset Utilization
Pre-FY23 not filed in verifiable form
Asset turnover needs a prior year of assets — omitted for the earliest available year.
06 · Asset Base Composition
Pre-FY23 not filed in verifiable form
07 · Debt Level & Coverage
Pre-FY23 not filed in verifiable form
08 · Profit & Loss
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| ₹1,187.10 Cr | ₹1,412.09 Cr | ₹1,681.56 Cr | ₹1,436.23 Cr | ₹1,666.53 Cr | ₹1,723.31 Cr | |
| EBITDA | ₹186.92 Cr | ₹185.84 Cr | ₹184.02 Cr | ₹204.82 Cr | ₹212.29 Cr | ₹107.60 Cr |
| — | — | ₹52.11 Cr | ₹-92.75 Cr | ₹-139.05 Cr | ₹27.63 Cr | |
| Diluted EPS | ₹3.68 | ₹4.56 | ₹3.33 | ₹-5.5 | ₹-8.03 | ₹1.44 |
Net income has filed figures for only some of the years shown — no further verified source covers the rest, so those years are left blank rather than estimated.
09 · Balance Sheet
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| ₹1,475.00 Cr | ₹1,790.00 Cr | ₹2,045.00 Cr | ₹1,972.00 Cr | ₹2,020.00 Cr | ₹2,320.00 Cr | |
| ₹549.99 Cr | ₹646.27 Cr | ₹800.54 Cr | ₹683.03 Cr | ₹651.80 Cr | ₹720.09 Cr | |
| Stockholders' equity | ₹644.00 Cr | ₹748.00 Cr | ₹820.00 Cr | ₹865.00 Cr | ₹902.00 Cr | ₹1,041.00 Cr |
Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.
10 · Cash Flow Statement
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| ₹117.00 Cr | ₹145.00 Cr | ₹51.00 Cr | ₹139.00 Cr | ₹23.00 Cr | ₹82.00 Cr | |
| Investing cash flow | ₹-132.86 Cr | ₹-249.13 Cr | ₹-124.63 Cr | ₹-66.50 Cr | ₹-75.35 Cr | ₹-52.95 Cr |
| ₹38.63 Cr | ₹135.97 Cr | ₹59.66 Cr | ₹-85.97 Cr | ₹76.17 Cr | ₹-24.63 Cr | |
| Capital expenditure | ₹-84.00 Cr | ₹-214.00 Cr | ₹-144.00 Cr | ₹-61.00 Cr | ₹-42.00 Cr | ₹-62.00 Cr |
| End cash position | ₹75.52 Cr | ₹107.81 Cr | ₹93.74 Cr | ₹80.25 Cr | ₹104.07 Cr | ₹108.56 Cr |
Annual only — the data source has no quarterly cash-flow-statement coverage.
11 · Shareholding Pattern
NSE, quarterly
| Line item | Sep 16–Dec 16(2Q) | Mar 17 | Jun 17 | Sep 17 | Nov 17 | Dec 17 | Mar 18 | Jun 18 | Sep 18 | Dec 18–Jun 19(3Q) | Sep 19 | Dec 19–Jun 20(3Q) | Sep 20 | Nov 20–Dec 20(2Q) | Mar 21 | Jun 21–Dec 21(3Q) | Feb 22–Mar 22(2Q) | Jun 22–Mar 23(4Q) | May 23–Jun 23(2Q) | Sep 23–Mar 24(3Q) | Jun 24–Dec 24(3Q) | Jan 25–Jun 25(3Q) | Sep 25 | Nov 25–Jun 26(4Q) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 41.14% | 40.95% | 40.96% | 40.93% | 35.08% | 35.05% | 22.37% | 22.39% | 22.49% | 22.66% | 22.70% | 22.85% | 22.84% | 21.74% | 21.73% | 21.71% | 17.65% | 17.64% | 16.52% | 48.03% | 48.02% | 49.10% | 49.08% | 48.03% |
| Public | 58.86% | 59.05% | 59.04% | 59.07% | 64.92% | 64.95% | 77.63% | 77.61% | 77.51% | 77.34% | 77.30% | 77.15% | 77.16% | 78.26% | 78.27% | 78.29% | 82.35% | 82.36% | 83.48% | 51.97% | 51.98% | 50.90% | 50.92% | 51.97% |
| Employee trusts | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Source: NSE quarterly shareholding-pattern filings, collapsed to periods where the reported percentages held steady — a column spanning several quarters means no change was filed across them. No FII/DII sub-split available from this source — Public includes all non-promoter, non-employee-trust holders.
12 · Peer Comparison
Basic Materials
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
| UltraTech Cement Limited | ₹3.17 L Cr | ₹11,014 | 36.9 | 4.13 | 10.7% | 0.31 | +16.6% | -12.8% |
| JSW Steel Limited | ₹3.06 L Cr | ₹1,275.6 | 12.4 | 3.06 | 22.3% | 1.19 | +9.3% | +13.8% |
| Hindustan Zinc Limited | ₹2.42 L Cr | ₹596 | 14.2 | 10.69 | 61.1% | 0.39 | +18.6% | +31.0% |
| Asian Paints Limited | ₹2.35 L Cr | ₹2,451.3 | 49.3 | 11.01 | 20.2% | 0.18 | +5.1% | -1.1% |
| Tata Steel Limited | ₹2.28 L Cr | ₹187.29 | 20.7 | 2.23 | 10.6% | 0.90 | +6.2% | +9.3% |
| Hindalco Industries Limited | ₹2.18 L Cr | ₹986.5 | 13.3 | 1.59 | 9.8% | 0.73 | +15.0% | +31.5% |
| Grasim Industries Limited | ₹2.15 L Cr | ₹3,209.2 | 37.9 | 2.08 | 4.8% | 2.20 | +18.2% | +11.5% |
| Solar Industries India Limited | ₹1.71 L Cr | ₹18,815 | 86.1 | 27.25 | 26.7% | 0.29 | +30.6% | +27.0% |
| Vedanta Aluminium Metal Limited | ₹1.60 L Cr | ₹416.5 | 42.1 | — | — | — | — | — |
| Pidilite Industries Limited | ₹1.58 L Cr | ₹1,572.1 | 59.8 | 14.58 | 22.6% | 0.04 | +11.1% | -48.5% |
| JINDAL STEEL LIMITED | ₹1.11 L Cr | ₹1,103 | 41.1 | 2.19 | 6.6% | 0.44 | +5.5% | +4.7% |
| Camlin Fine Sciences Limited | ₹1,868.67 Cr | ₹97.28 | — | 1.80 | 2.7% | 0.69 | +7.1% | -57.4% |
Ranked by market cap within Basic Materials, same metrics as the Fundamentals screener. Click a column to sort.
Documents
Annual reports
Show all 20
Concall transcripts
Show all 17
Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.
Index membership
4 indices
Weight is BSE’s own published index weight. Indices without weight data are listed without one, in alphabetical order after the weighted ones.
Camlin Fine Sciences CAMLINFINE Postal Ballot Director Appointment
Kalkine India · 3 days ago